newsfilter
← Latest News
PR Newswire·

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

DISCO Pharmaceuticals ("DISCO"), a specialist biotech unlocking the surfaceome of cancer cells at scale to identify new targets and develop first in...